Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the latter part of the year.
Related Posts
Trump Media sues Brazil Supreme Court justice who once crossed Musk
Brazil Supreme Court Justice Alexandre de Moraes is alleged to have been targeted for death in a plot that included former Brazil President Jair Bolsonaro.
OpenAI says it needs ‘more capital than we’d imagined’ as it lays out for-profit plan
OpenAI said in a blog post Friday that heading into 2025, “we have to becomean enduring company,” which requires changing its structure.
Bluesky CEO Jay Graber says X rival is ‘billionaire proof’
Bluesky CEO Jay Graber told CNBC that the social media app’s open design could thwart potential acquisition efforts.